Taipei, Taiwan, February 20th, 2023 / Sciad Newswire / BRIM Biotechnology, Inc. (BRIM, TPEx 6885), a clinical-stage company developing novel regenerative therapies to help combat and cure ophthalmology and degenerative joint diseases, is pleased to announce that Andrew Lin was elected as the new Chairman of the Boar.
Taipei, July 28 (CNA) The 2022 BIO Asia-Taiwan International Conference and Exhibition kicked off in Taipei on Thursday, bringing together around 550 manufacturers in the biotechnology and pharmaceutical industry from 15 countries to showcase their offerings, according to event organizers.